NCT03014284 Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis Status WITHDRAWN Phase N/A
NCT02709213 Determination of the Aetiologies of Acute Colitis and Early Identification of Patients Requiring Diagnostic Colonoscopy Status COMPLETED Phase N/A
NCT02687724 Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis Status UNKNOWN Phase PHASE4
NCT02647866 Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02600143 Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy. Status COMPLETED Phase N/A
NCT02569333 Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis Status COMPLETED Phase NA
NCT02063282 The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers Status COMPLETED Phase N/A
NCT01369355 A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) Status COMPLETED Phase PHASE3
NCT01369342 A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) Status COMPLETED Phase PHASE3
NCT01369329 A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1) Status COMPLETED Phase PHASE3
NCT01326013 A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel Status COMPLETED Phase N/A
NCT00936585 NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease Status TERMINATED Phase NA
NCT00533078 Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies Status COMPLETED Phase PHASE2
NCT00514982 Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome Status WITHDRAWN Phase PHASE2